Skip to content

A study to test the safety and efficacy of EP102 in patients with advanced solid tumours

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-521305-40-00
Enrollment
86
Registered
2025-07-15
Start date
2025-07-22
Completion date
Unknown
Last updated
2025-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Participants with Advanced Solid Tumors

Interventions

None listed

Sponsors

Epics Therapeutics
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Belgium, Czechia, France, Netherlands, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026